A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures

1998209 citationsJournal Article

Authors

Gabapentin at 900 or 1,800 mg/day is effective and safe as monotherapy for patients with newly diagnosed partial epilepsy.

Good health and well-being

Published in: Neurology

Volume 51, Issue 5, pp. 1282-1288

Field-Weighted Citation Impact: 10.25